Northland Capmk Brokers Reduce Earnings Estimates for DocGo

DocGo Inc. (NASDAQ:DCGO) – Equities research analysts at Northland Capmk decreased their Q2 2025 earnings per share (EPS) estimates for DocGo in a note issued to investors on Sunday, May 11th. Northland Capmk analyst M. Latimore now anticipates that the company will post earnings per share of ($0.07) for the quarter, down from their previous forecast of $0.03. The consensus estimate for DocGo’s current full-year earnings is $0.25 per share. Northland Capmk also issued estimates for DocGo’s Q3 2025 earnings at ($0.06) EPS, Q4 2025 earnings at ($0.05) EPS and FY2025 earnings at ($0.26) EPS.

A number of other research firms have also weighed in on DCGO. Needham & Company LLC dropped their target price on DocGo from $4.00 to $3.00 and set a “buy” rating on the stock in a report on Friday, May 9th. Canaccord Genuity Group restated a “hold” rating and issued a $1.45 target price (down previously from $5.00) on shares of DocGo in a report on Monday. Stifel Nicolaus dropped their target price on DocGo from $6.50 to $5.50 and set a “buy” rating on the stock in a report on Friday, February 28th. BTIG Research lowered DocGo from a “buy” rating to a “neutral” rating in a report on Friday, May 9th. Finally, Deutsche Bank Aktiengesellschaft lowered DocGo from a “buy” rating to a “hold” rating and dropped their price target for the stock from $5.00 to $2.85 in a report on Friday, February 28th. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $3.56.

DocGo Stock Performance

Shares of NASDAQ:DCGO opened at $1.50 on Wednesday. The business’s 50 day simple moving average is $2.45 and its two-hundred day simple moving average is $3.66. The firm has a market cap of $152.97 million, a P/E ratio of 5.36, a PEG ratio of 14.16 and a beta of 1.14. DocGo has a 52-week low of $1.35 and a 52-week high of $5.68.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings results on Thursday, May 8th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.08). The firm had revenue of $96.03 million during the quarter, compared to the consensus estimate of $104.25 million. DocGo had a return on equity of 8.90% and a net margin of 4.35%.

Institutional Trading of DocGo

Large investors have recently bought and sold shares of the company. Summit Investment Advisors Inc. increased its position in DocGo by 38.7% in the fourth quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company’s stock worth $45,000 after buying an additional 2,968 shares during the last quarter. Summit Securities Group LLC purchased a new position in shares of DocGo in the first quarter valued at $34,000. Prudential Financial Inc. purchased a new position in shares of DocGo in the fourth quarter valued at $55,000. Royce & Associates LP purchased a new position in shares of DocGo in the fourth quarter valued at $64,000. Finally, Boothbay Fund Management LLC grew its position in shares of DocGo by 154.9% in the fourth quarter. Boothbay Fund Management LLC now owns 27,445 shares of the company’s stock valued at $116,000 after purchasing an additional 77,445 shares in the last quarter. 56.44% of the stock is owned by hedge funds and other institutional investors.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.